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ACE/Ang II/AT1R axis and ACE2/Ang 1-7/Mas1 axis via p38MAPK signaling
pathway. Hence, CREG is an important negative regulator of Ang II-induced hy-
pertension and suppresses adverse vascular remodeling, leading to a new thera-
peutic approach to the treatment of hypertensive vascular remodeling.
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Objectives: The proliferation of cardiac ﬁbroblast cells (CFs) contribute to the
development of cardiac remodeling which will ultimately lead to cardiac remolding. In
this study, we have investigated the effect and molecular mechanisms of hesperetin
(HES) on the Angiotensin II (Ang II) -induced proliferation of primary cultured rat
CFs.
Methods: When CFs received different factor intervention for 24h; the toxicity of
HES on CFs was determined by the trypan blue exclusion test; cell proliferation was
determined using a non-radioactive colorimetric Cell Counting Kit CCK-8 assay,
DNA syntheses of the CFs were assessed by measuring the incorporation of BrdU;
Cell cycle progression was determined using ﬂuorescence-activated cell sorting
(FACS); the mRNA expression associated with the cell cycle was testing by RT-PCR;
Western blot domenstrated the signaling pathway.
Results: Our data demonstrated that HES signiﬁcantly inhibited the proliferation of
CFs induced by Ang II in a dose-dependent manner without cell cytotoxicity (both of
DNA and proteins synthesis levels). In accordance with these ﬁndings, HES blocked
progression through G0/G1 to S phase of the cell cycle. We also demonstrated that
HES inhibit the cell cycle was associated with the inhibition of the mRNA expression
of cyclin D1, CDK6, as well as an increase of the mRNA and protein expression of
p21/WAF in Ang II-stimulated CFs. Further studies showed that the beneﬁcial effect
of HES on blocking the proliferation of CFs is related to suppression of the AKT/
GSK3b signaling pathway, but has little effect on the extracellular signal-regulated
kinase (ERK) 1/2, p38 and JNK signaling pathways.
Conclusions: These results demonstrate that HES suppresses Ang II-induced CFs
proliferation through the AKT/GSK3b signaling pathway and suggests that it may be
a feasible therapy for cardiac remodeling diseases.
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Objective: To identify the drug-drug interaction of clopidogrel and atorvastatin based
on bioinformatic analysis.
Methods: this study conducted cell-based microarray and bioinformatic analysis of
the impact of atorvastatin and clopidogrel carboxylic acid exposure on endothelial cell
response. human umbilical vein endothelial cell line EA.hy926 were treated with
10mM of atorvastatin or 10mM of clopidogrel carboxylic acid for 24 h, then the cell-
based microarray were performed. Gene set enrichment analysis (GSEA), Database
for Annotation, Visualization, and Integrated Discovery (DAVID) and the cMap
database were used to analysis the gene expression data. The target differenced genes
of atorvastatin and clopidogrel carboxylic acid were validated by real-time polymerase
and Weston-blot.
Results: A total of 649 genes were found to show at least 2-fold changes in
EA.hy926 cells after treatment with atorvastatin, including 295 up-regulated and 354
down-regulated genes. The bioinformatics analysis using GSEA and DAVID
revealed that Kruppel-like factors (KLFs) and cell-cycle related genes are the genes
most signiﬁcantly affected by atorvastatin treatment. The cMap analysis suggested
that atorvastatin acted as an HDAC inhibitor and similar with resveratrol. A total of
235 genes were found to show at least 1.5-fold changes in EA.hy926 cells after
treatment with clopidogrel carboxylic acid, including 176 up-regulated and 59 down-
regulated genes. The bioinformatics analysis showed that genes belonged to Toll-like
receptor, Nod-like receptor signaling pathway and IL-6 signaling pathway were up-
regulated, the regulation of transcription, RNA formation and signal transduction
were also affected by clopidogrel carboxylic acid. The cMap analysis suggested that
clopidogrel carboxylic acid was similar with 15d-PGJ2. The up-regulation of KLFs
and the down-regulation of cell-cycle related genes, including CCNA2, CCNE2,
CCNB1, CCNB2, FOS, IL-8 et al were validated by real-time polymerase chain
reaction (RT-PCR) andWeston-blot. The results were consistent with the microarray
data.
Conclusion: Atorvastatin played the anti-atherosclerotic role through through multi-
ple mechanisms. The mechanism may be similar to the HDAC inhibitors and
resveratrol; clopidogrel carboxylic acid increases inﬂammatory gene pathway, and
was similar to the mechanism of 15d-PGJ2. From gene expression proﬁles analysis,
there was no signiﬁcant antagonism between atorvastatin and clopidogrel carboxylic
acid.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e5370
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Objectives: Observation the roles of P2X7R in atherosclerosis. Investigate the
mechanism of NLRP3 inﬂammasome activated in atherosclerosis.
Methods: We also observed the expression and distribution of P2X7R and NLRP3 in
the atherosclerosis plaque of coronary artery from autopsy by immunoﬂuorescence.
The expressions of P2X7R, NLRP3, IL-1bof THP-1 macrophages were observed by
Real-time PCR and western blot. The level of IL-1b in the media supernatant and mice
plasma was assayed by ELISA. The co-immunoprecipitation was used to observe the
interaction between PKR phosphorylation and NLRP3. Finally, expressions of P2X7R
and PKR phosphorylation were observed in apoE-/- mice aortic sinus by immuno-
histochemistry and immunoﬂuorescence.
Results: The expression of P2X7R and NLRP3 in the human plaque is extremely
intensity co-location with macrophages by Immunoﬂuorescence. In vitro, We found
the concentration of IL-1b in culture medium from THP-1 treated by 100mg/ml for 24
hours is higher than control group. (321.9377.7 pg/ml, vs 8.802.05pg/ml,
P<0.01). And the expressions of proIL-1b, P2X7R and NLRP3 in cytoplasm of THP-
1 cells incubated by oxLDL were up-regulation. And lots of mature IL-1b were
produced. Although NLRP3 was knocked down by siRNA, the expression of proIL-
1b kept the high level. However, the level of mature IL-1b in the NLRP3 siRNA
group prominent lower than the negative control. In vitro, Incubation with P2X7R
siRNA, the expressions of proIL-1b in THP-1 by oxLDL were not decreased.
However, the IL-1b activation was inhibited. The concentration of IL-1b in culture
medium, which in the P2X7R siRNA group, was signiﬁcantly lower, compared to the
negative control (67.3518.72 pg/ml vs 340.78101.88pg/ml,P<0.01). Co-immu-
noprecipitation indicates when P2X7R inhibited by siRNA, PKR phosphorylation was
lower signiﬁcantly, and NLRP3 interacting with PKR phosphorylation was sup-
pressed. And then, the activated caspase-1 was also reduced. In vivo, for 12 weeks
high cholesterol diet, In the lesions of apoE-/- mice aortic sinus., P2X7R expression
was intensive. The ELISA indicated IL-1b in plasma of apoE-/- mice fed by high
cholesterol diet for 4weeks, 8weeks, 12weeks prominent higher than control
(51.5613.28 pg/ml,140.2736.11 pg/ml,171.3445.21 pg/ml,vs 8.872.27 pg/
ml,P<0.01). Compared to apoE-/- and apoE-/-NC (negative control), the atheroscle-
rosis in apoE-/-P2X7R-/- was attenuated. The IL-1b level in plasma of apoE-/-P2X7R-/-
mice was lower than control and negative control (81.5725.79pg/ml vs
157.3340.01 pg/ml,P<0.05;81.5725.79pg/ml vs 160.3235.59 pg/ml P<0.05).
PKR phosphorylation levels was elevating in the locaiton of P2X7R positive with
atherosclerosis developement.
Conclusions: oxLDL could promote expressions of proIL-1b, NLRP3 and P2X7R in
macrophages.P2X7R regulates the assemble and activation of NLRP3 inﬂammasome
by controlling the level of PKR phosphorylation, but P2X7R could not regulate the
expression of NLRP3 mRNA and protein directly.P2X7R plays important roles in the
apoE-/- mice atherosclerosis development.
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Objectives: MicroRNAs play key roles in atherosclerosis-related diseases. However,
the effects of miR-146a, miR-125a, and miR-34b/c polymorphisms on coronary artery
disease (CAD) and acute myocardial infarction (AMI) susceptibility have not been
explored.
Methods: A cross-sectional study examined patients with CAD. The rs2910164 (miR-
146a), rs12976445 (miR-125a) and rs4938723 (miR-34b/c) polymorphisms were
analyzed using SNPshot minisequencing. The association between the risk genotype
and the proportion of patients with 3-vessel disease, 1-vessel disease, left main trunk
disease, and coronary artery bypass graft surgery was tested, as was its association
with the modiﬁed Gensini coronary scoring indexes. All patients were experienced
follow-up for 102 weeks. The miR-146aC>G polymorphism was obviously associ-
ated with CAD and AMI prevalence.
Results: A multivariate logistic regression analysis indicated that the genotype dis-
tribution of the rs2910164 polymorphism was associated signiﬁcantly with the
angiographical characteristics of coronary atherosclerosis risk. The variant genotypes
GG of rs2910164 (miR-146a) were associated with a signiﬁcantly increased risk of
CHD (adjusted OR¼2.481, 95% CI¼1.151-5.346) and coronary stenosis (adjusted
OR¼2.280, 95% CI¼1.130-4.599), compared with genotype CC. The miR-125a and
miR-34b/c polymorphisms were not associated with risk of CAD. Among CAD cases,
3-vessel disease demonstrated a strong, direct association with the variant genotypesasic and Translational Medicine C15
GG of rs2910164 (miR-146a) (P<0.01). Cox regression analysis showed that the
miR-146aC>G polymorphism was associated with serious prognosis of CAD.
Conclusions: The miR-146aG allele is associated with pathogenesis and prognosis of
CAD, especially for AMI patients.
Funding: This work was supported by the National Basic Research Program of
China (“973 Project”No. 2012CB517804).
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Objectives: Pulmonary arterial hypertension (PAH), which is characterized by a pro-
gressive elevation of pulmonary vascular resistance and leads to right heart failure and
even death. Basis of the “Warburg effect”, the metabolism shifts from oxidative mito-
chondria to glycolysis and the elevated enzyme hexokinase-2 (HK2) in PAH. An in-
hibitor of HK2, 3-bromopyruvate (3-BrPA), promptly and substantially suppresses ATP
and lactic acid, however, it could prevents the development of PAH is not yet known.
Methods: Sprague-Dawley rats with monocrotaline (MCT, 60 mg/kg) -induced PAH
were administered subcutaneous injection of 3-BrPA (7.5mg/kg/d, 15mg/kg/d and
30mg/kg/d, respectively) for 14 days. Hemodynamic parameters were acquired by
right heart catheterization. Histopathology, immunohistochemisty, and assessments of
relative enzyme expressions were performed in rat lung tissue.
Results: Compared with MCT rats, 3-BrPA signiﬁcantly decreased mean pulmonary
arterial pressure; pulmonary vascular resistance (PVR) and right heart hypertrophy
(RVH), and increased cardiac output. In additional, 3-BrPA treatment markedly
reduced MCT-induced increase in both the wall thickness and area. 3-BrPA signiﬁ-
cantly suppressed proliferation and enhanced apoptosis of pulmonary artery smooth
muscle cells, attenuating small pulmonary artery remodeling. Furthermore, treatment
with 3-BrPA signiﬁcantly increased endothelial NO synthase expression, cytochrome
c in cytoplasm and superoxide dismutase activity, and down-regulated HK2 expres-
sion and ATP production.
Conclusions: These investigations demonstrated the importance of glycolytic inhibi-
tion in PAH pathogenesis and highlight 3-BrPA may beneﬁcial to the therapy of PAH.
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Cortistatin protects myocardium from endoplasmic reticulum stress induced
apoptosis during sepsis
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Objectives: Sepsis is generally viewed as a disease aggravated by a systemic in-
ﬂammatory response to infection. Myocardial depression is a well-recognized mani-
festation of organ dysfunction in sepsis, and myocardial apoptosis is a key step for this
progression. Cortistatin (CST), a cyclic neuropeptide related to somatostatin, prevents
septic shock-associated lung and liver injury, and improves survival in experimental
sepsis. However, the effect of CST on myocardium remains unclear. This study aimed
to assess whether CST protects the myocardium from sepsis-induced apoptosis.
Methods: To test that, the murine model of cecal ligation and puncture (CLP) and
LPS induced cardiomyocytes (CM) were used in vitro. To measure rat CST and its
receptors mRNA levels, we used real-time PCR. Electron microscopy, TUNEL
staining, caspase-3 activity and Bcl-2/Bax ratio were used to determine myocardial
apoptosis. Western-blot was used to test endoplasmic reticulum stress markers, such
as GRP94, caspase-12 and CHOP.
Results: Compared with the sepsis-alone group, rats under CST treatment showed
higher MABP, by 37.8%. And CST elevated values of +LVdp/dtmax by 54.1%, and
LVdp/dtmax by 48.3%, and LVSP by 27.5%. We further conﬁrmed that by using
TUNEL staining and caspase-3 activity assay, and showed there is a signiﬁcant
decrease of cardiomyocytes apoptosis after CST pretreatment. On Western blot
analysis, compared with sepsis group the ratio of Bcl-2/Bax increased by 2.6-fold in
the CST+sepsis group (P<0.05). We further investigated the expression of ERS
marker: the protein levels of GRP94, caspase-12, CHOP were about 2.7-fold, 9.2-fold,
6.2-fold (all P<0.05) higher, respectively, in sepsis than control myocardium; how-
ever, the upregulated expression of these proteins was downregulated with CST
treatment, by 52.8%, 29.5%, 36.6% (all P<0.05) respectively. In vitro, we also found
that CST treatment signiﬁcantly decrease LPS induced these molecules expression. To
further investigate the direct inhibitory effect of CST on ERS in vitro, we used DTT to
induce cardiomyocytes. The protein levels of ERS markers were signiﬁcantly
increased after chemicals incubation for 3h. Preincubation with cortistatin abolished
the increased levels of ERS markers. We found that D-GHRP-6, GHS-R1a antagonist
completely blocked cortistatin’s inhibitory effect on cardiomyocyte ERS, indicating
CST inhibit ERS through GHS-R1a.
Conclusions: In conclusion, CST pretreatment attenuated sepsis induced depressed
cardiac function and apoptosis and inhibited the overexpression of ERS markers. In
vitro, CST directly inhibited ERS, which might depend on GHS-R1a. For the ﬁrst
time, we show that CST protects heart against sepsis injury and apoptosis, at least
partially through its inhibitory effect on myocardial ERS and through activation its
receptor GHS-R1a, which may provide a new insight into the mechanism underlying
the wide cardiovascular protective actions of CST atin.C16 JACC Vol 64/16/Suppl C j OctobGW25-e0051
Suppression of cardiac TFEB sumoylation promotes age-associated reduction in
autophagy
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Objectives: Aging-dependent decline of autophagy contributes to cardiac dysfunction
and ischemic intolerance. Transcription factor EB (TFEB) is a master transcriptional
regulator of the autophagy-lysosome pathway. The present study aimed to characterize
the role of TFEB in the autophagic decrease with aging.
Methods: We analyzed age-associated autophagic changes in male C57BL/6 young
(4-6 mo) and aged (22-24 mo) mice.
Results: The results demonstrated that TFEB expressed predominantly as a
SUMOylated form in cardiomyocyte nuclei and this SUMOylation of TFEB declined
in aged heart associated with autophagy reduction. Interestingly, SUMOylation of
TFEB was unaffected by rapamycin. Rapamycin induced translocation of TFEB into
nucleus but lower level of nuclear TFEB in aged hearts than that seen in young hearts
(P<0.05). SUMO1 downregulation by adeno-associated-virus-mediated small hairpin
RNA (rAAV9-shSUMO1) signiﬁcantly reduced nuclear TFEB levels (P<0.05),
depressed cardiac autophagy and accelerated cardiomyocyte contractile dysfunction
with worse hypoxia/reoxygenation (H/R) injury (all P<0.05). Therefore, impaired
SUMOylation decreased nuclear TFEB during aging. By contrast, SUMO1 restitution
signiﬁcantly augmented nuclear SUMOylated TFEB with enhanced autophagy and
ultimately reduced infarct size in aged heart. However, knockdown of cardiac TFEB
blocked the protective effect of upregulation of SUMO1 in aged hearts, resulted in
decline of autophagy and worse in vivo I/R injury.
Conclusions: The present study newly demonstrates that SUMOylation is a critical
post-translational modiﬁcation that regulates cardiac TFEB. Impaired SUMOylation
of TFEB aggravates decline of autophagy in the senescent heart. Targeting SUMO1
may provide a novel therapeutic strategy for the treatment of aging-related loss of
cardioprotection.
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Effect of Xiongdan on Blood Pressure, Mesenteric Vascular Structure and
Function in Spontaneously Hypertensive Rats
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Objectives: To observe the effect of Xiongdan on blood pressure, vascular structure
and dilatation function of 3rd grade branch mesenteric arteries in spontaneously hy-
pertensive rats (SHRs).
Methods: Sixteen male SHRs at 12 wks old were randomly divided into 2 groups:
Xiongdan (SHR-X, n¼8, a traditional Chinese herbal compound, 800mg$kg-1$d-1)
and untreated controls (SHR, n¼8). Age- and weight-matched WKY rats served as
controls (WKY, n¼8). Systolic blood pressure (SBP) was measured by tail-cuff
method before treatment, 4 and 8 wks after treatment. The wall-to-lumen area ratios
(W/L), the ratios of wall thickness (WT) to lumen radius (LR) of 3rd grade branch
mesenteric arteries were assessed morphometrically. Endothelium-dependent relaxa-
tion (EDdR), endothelium-independent relaxation (EDiR) was measured by PowerLab
biological signal analytical system.
Results: SBP in SHRs were higher than that in WKY from 12 to 20 wks. SBP in X
treated rats was signiﬁcantly lower than that in untreated rats [SBP/mmHg, 4wks:
SHR-X 176.4511.44 vs SHR 200.2713.94; 8wks: SHR-X 169.4311.97 vs SHR
189.8810.06, both P<0.01]. W/L and WT/LR of 3rd grade branch mesenteric
arteries in X treated rats were markedly lower than that of untreated SHR [W/L:
SHR-X 0.530.09 vs SHR 1.820.96; WT/LR: SHR-X 0.240.08 vs SHR
0.530.29, both P<0.01], similar to the level as that of WKY ( P>0.05). Compared
with SHR, EDdR [Emax/%: SHR-X 59.2915.15 vs SHR: 20.696.31, pD2 : SHR-
X 8.240.13 vs SHR 5.820.23; both P <0.01] and EDiR [Emax/%: SHR-X
96.371.87 vs SHR 29.044.56, pD2: SHR-X 7.790.15 vs SHR 5.310. 14; both
P<0.01] of 3rd grade branch mesenteric arteries were increased in X treated after
8wks treatment.
Conclusions: The treatment of Xiongdan may lower blood pressure, ameliorate the
vascular structure and dilatation function of 3rd grade branch mesenteric arteries in
SHRs.
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Objectives: Adverse environmental exposure in utero predisposes to adult disease,
including hypertension. Exposure to lipopolysaccharide (LPS) results in increased
blood pressure in offspring, but the exact mechanisms are not clear. Our previous
study shows dysfunction of renal D1 receptor (D1R) is ascribed to the pathogenesis of
hypertension, which is associated with reactive oxidative stress (ROS). In this study,
we test whether dysfunction of renal D1R is involved in fetal programmed hyper-
tension, and whether oxidative stress contributes to this process.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
